Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 42,143,638
- Share change
- +591,010
- Total reported value
- $376,757,638
- Put/Call ratio
- 83%
- Price per share
- $8.94
- Number of holders
- 100
- Value change
- -$18,208,642
- Number of buys
- 52
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 007002108:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
78%
|
7,447,140
|
$105,898,000 | — | 30 Sep 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
44%
|
4,241,472
|
$60,314,000 | — | 30 Sep 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
25%
|
2,443,246
|
$34,743,000 | — | 30 Sep 2022 | |
| Abingworth LLP |
13F
|
Company |
22%
|
2,115,385
|
$30,017,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
22%
|
2,109,787
|
$30,003,000 | — | 30 Sep 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
21%
|
2,059,372
|
$29,284,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
20%
|
1,958,265
|
$27,847,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
17%
|
1,660,667
|
$23,616,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
1,499,259
|
$21,319,000 | — | 30 Sep 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
15%
|
1,452,109
|
$20,650,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
15%
|
1,400,000
|
$19,908,000 | — | 30 Sep 2022 | |
| Polar Capital Holdings Plc |
13F
|
Company |
13%
|
1,293,670
|
$18,396,000 | — | 30 Sep 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
9.7%
|
935,766
|
$13,307,000 | — | 30 Sep 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
8.6%
|
825,508
|
$11,739,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
8.4%
|
809,351
|
$11,509,000 | — | 30 Sep 2022 | |
| JOHNSON & JOHNSON |
13F
|
Company |
7.6%
|
728,944
|
$10,366,000 | — | 30 Sep 2022 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
7.1%
|
680,000
|
$9,670,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
7%
|
675,976
|
$9,612,000 | — | 30 Sep 2022 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
6%
|
580,000
|
$8,248,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.6%
|
538,495
|
$7,657,000 | — | 30 Sep 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
5.1%
|
491,965
|
$6,996,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
4.4%
|
417,863
|
$5,942,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.1%
|
395,081
|
$5,618,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.1%
|
389,926
|
$5,545,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.7%
|
261,527
|
$3,719,000 | — | 30 Sep 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
2.5%
|
244,400
|
$3,475,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.5%
|
240,997
|
$3,427,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
2.2%
|
212,404
|
$3,020,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.2%
|
210,696
|
$2,996,000 | — | 30 Sep 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.9%
|
181,626
|
$2,583,000 | — | 30 Sep 2022 | |
| Foresite Capital Opportunity Management V, LLC |
13F
|
Company |
1.8%
|
170,000
|
$2,417,000 | — | 30 Sep 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
1.6%
|
154,708
|
$2,195,000 | — | 30 Sep 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
1.6%
|
150,000
|
$2,133,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
134,491
|
$1,913,000 | — | 30 Sep 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
1.4%
|
131,509
|
$1,870,000 | — | 30 Sep 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.3%
|
124,379
|
$1,769,000 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.3%
|
121,471
|
$1,727,318 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
120,782
|
$1,718,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
1.3%
|
120,107
|
$1,708,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
113,834
|
$1,619,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
112,853
|
$1,605,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
112,355
|
$1,598,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.1%
|
109,389
|
$1,556,000 | — | 30 Sep 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.99%
|
95,089
|
$1,350,000 | — | 30 Sep 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.95%
|
90,849
|
$1,292,000 | — | 30 Sep 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.88%
|
84,548
|
$1,202,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.86%
|
82,407
|
$1,172,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
75,316
|
$1,071,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.67%
|
64,000
|
$910,000 | — | 30 Sep 2022 | |
| J. Goldman & Co LP |
13F
|
Company |
0.59%
|
57,094
|
$812,000 | — | 30 Sep 2022 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2022
As of 31 Dec 2022,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,143,638 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, COWEN AND COMPANY, LLC, BlackRock Inc., STATE STREET CORP, Abingworth LLP, VANGUARD GROUP INC, MORGAN STANLEY, and Polar Capital Holdings Plc.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
98
Q4 2022 holders
100
Holder diff
2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.